Metabolic bone diseases: translational research-preventing fractures with denosumab.
Ebeling
Peter R
PR
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001851:Bone Diseases, Metabolic / Q000188:drug therapy*; D000069448:Denosumab; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D008297:Male; D053245:RANK Ligand / Q000494:pharmacology / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053245:RANK Ligand; D000069448:Denosumab